Establishment of a biological assay system for human retroviral protease activity

Microbes and Infection

Volumn 7, Issue 5-6, 2005, Pages 820-824

  Yoshida, Akiko ^a   Piroozmand, Ahmad ^a   Sakurai, Akiko ^a   Fujita, Mikako ^a   Uchiyama, Tsuneo ^a   Kimura, Tooru ^b   Hayashi, Yoshio ^b   Kiso, Yoshiaki ^b   Adachi, Akio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

HIV 1; HTLV 1; Luciferase; Retroviral protease

Indexed keywords

ANTIVIRUS AGENT; LUCIFERASE; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; VIRUS ENZYME; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; BIOASSAY; CELL LINE; COCULTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROTEINASE INHIBITION; RETROVIRUS; SENSITIVITY ANALYSIS; VIRUS INFECTION;

ANTIVIRAL AGENTS; CELL LINE; COCULTURE TECHNIQUES; GENE EXPRESSION; GENES, REPORTER; HIV-1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LUCIFERASES; LYMPHOCYTES; SAQUINAVIR;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T LYMPHOTROPIC VIRUS TYPE 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 20444474853     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.02.008     Document Type: Article

References (28)

1. M. Yoshida, I. Miyoshi, and Y. Hinuma Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease Proc. Natl. Acad. Sci. USA 79 1982 2031 2035
2. A. Gessain, F. Barin, J.C. Vernant, O. Gout, L. Maurs, A. Calender, and G. De The Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis Lancet ii 1985 407 410
3. M. Osame, K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara HTLV-I associated myelopathy, a new clinical entity Lancet i 1986 1031 1032
4. K. Barmak, E. Harhaj, C. Grant, T. Alefantis, and B. Wigdahl Human T-cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration Virology 308 2003 1 12
5. M. Osame, M. Matsumoto, K. Usuku, S. Izumo, N. Ijichi, H. Amitani, M. Tara, and A. Igata Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells Ann. Neurol. 21 1987 117 122
6. M. Mori, K. Kinoshita, N. Ban, Y. Yamada, and H. Shiku Activated T-lymphocytes with polyclonal gammopathy in patients with human T-lymphotropic virus type I-associated myelopathy Ann. Neurol. 24 1988 280 282
7. M. Yoshida, M. Osame, H. Kawai, M. Toita, N. Kuwasaki, Y. Nishida, Y. Hiraki, K. Takahashi, K. Nomura, S. Sonoda, N. Eiraku, S. Ijichi, and K. Usuku Increased replication of HTLV-I in HTLV-I-associated myelopathy Ann. Neurol. 26 1989 331 335
8. S.J. Greenberg, S. Jacobson, T.A. Waldmann, and D.E. McFarlin Molecular analysis of HTLV-I proviral integration and T-cell receptor arrangement indicates that T cells in tropical spastic paraparesis are polyclonal J. Infect. Dis. 159 1989 741 744
9. M. Nishimura, A. Adachi, I. Akiguchi, N. Shirahata, M. Maeda, A. Ishimoto, T. Mezaki, and J. Kimura High ratio of HTLV-1-infected cells in HTLV-1 associated myelopathy (HAM) Acta Neurol. Scand. 81 1990 209 214
10. K. Nagasato, T. Nakamura, K. Ohishi, K. Shibayama, M. Motomura, and K. Ichinose Active production of anti-human T-lymphotropic virus type I (HTLV-I) IgM antibody in HTLV-I-associated myelopathy J. Neuroimmunol. 32 1991 105 109
11. J. Kira, Y. Koyanagi, T. Yamada, Y. Itoyama, I. Goto, N. Yamamoto, H. Sasaki, and Y. Sakaki Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study Ann. Neurol. 29 1991 194 201
12. R. Kubota, T. Fujiyoshi, S. Izumo, S. Yashiki, I. Maruyama, M. Osame, H. Sasaki, and Y. Sakaki Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy J. Neuroimmunol. 42 1993 147 154
13. R. Kubota, F. Umehara, S. Izumo, S. Ijichi, K. Matsumoto, S. Yashiki, T. Fujiyoshi, S. Sonoda, and M. Osame HTLV-I proviral DNA amounts correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy J. Neuroimmunol. 53 1994 23 29
14. T. Nagao, A. Yoshida, A. Sakurai, A. Piroozmand, A. Jere, M. Fujita, T. Uchiyama, and A. Adachi Determination of HIV-1 infectivity by lymphocytic cell lines with integrated luciferase gene Int. J. Mol. Med. 14 2004 1073 1076
15. N. Fan, J. Gavalchin, B. Paul, K.H. Wells, M.J. Lane, and B.J. Poiesz Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I J. Clin. Microbiol. 30 1992 905 910
16. D. Derse, S.A. Hill, P.A. Lloyd, H.K. Chung, and B.A. Morse Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors J. Virol. 75 2001 8461 8468
17. J.S. Lebkowski, S. Clancy, and M.P. Calos Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression Nature 317 1985 169 171
18. D.L. Mann, S.J. O'Brien, D.A. Gilbert, Y. Reid, M. Popovic, E. Read-Connole, R.C. Gallo, and A.F. Gazdar Origin of the HIV-susceptible human CD4+ cell line H9 AIDS Res. Hum. Retroviruses 5 1989 253 255
19. S. Harada, Y. Koyanagi, and N. Yamamoto Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay Science 229 1985 563 566
20. R. Shibata, M. Kawamura, H. Sakai, M. Hayami, A. Ishimoto, and A. Adachi Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells J. Virol. 65 1991 3514 3520
21. A. Adachi, H.E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M.A. Martin Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone J. Virol. 59 1986 284 291
22. R.L. Willey, D.H. Smith, L.A. Lasky, T.S. Theodore, P.L. Earl, B. Moss, D.J. Capon, and M.A. Martin In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity J. Virol. 62 1988 139 147
23. H. Sakai, R. Shibata, J. Sakuragi, T. Kiyomasu, M. Kawamura, M. Hayami, A. Ishimoto, and A. Adachi Compatibility of rev gene activity in the four groups of primate lentiviruses Virology 184 1991 513 520
24. R.A. Furuta, K. Sugiura, S. Kawakita, T. Inada, S. Ikehara, T. Matsuda, and J. Fujisawa Mouse model for the equilibration interaction between the host immune system and human T-cell leukemia virus type 1 gene expression J. Virol. 76 2002 2703 2713
25. E. Bohnlein, M. Siekevitz, D.W. Ballard, J.W. Lowenthal, L. Rimsky, H. Bogerd, J. Hoffman, Y. Wano, B.R. Franza, and W.C. Greene Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins J. Virol. 63 1989 1578 1586
26. H. Cheng, J. Tarnok, and W.P. Parks Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat J. Virol. 72 1998 6911 6916
27. T. Murakami, S. Ablan, E.O. Freed, and Y. Tanaka Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity J. Virol. 78 2004 1026 1031
28. S.C. Pettit, R. Sanchez, T. Smith, R. Wehbie, D. Derse, and R. Swanstrom HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells AIDS Res. Hum. Retroviruses 14 1998 1007 1014